Sarcoma  >>  chiauranib (CS 2164)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
chiauranib (CS 2164) / Chipscreen
NCT05497843: Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS)

Recruiting
2
40
RoW
Chiauranib, CS2164
Chipscreen Biosciences, Ltd.
Soft Tissue Sarcoma
02/24
06/24
NCT05542433: Phase II Study of Chiauranib Capsule in Advanced or Unresectable Soft Tissue Sarcoma

Recruiting
2
30
RoW
Chiauranib, Chiauranib Capsules
Sun Yat-sen University, Shenzhen Chipscreen Biosciences Co.Ltd
Soft Tissue Sarcoma
08/24
08/24

Download Options